96 related articles for article (PubMed ID: 1948130)
1. In vitro data supporting interferon plus cytotoxic agent combinations.
Von Hoff DD
Semin Oncol; 1991 Oct; 18(5 Suppl 7):58-61. PubMed ID: 1948130
[TBL] [Abstract][Full Text] [Related]
2. Rationale for and conduct of a phase I clinical trial with interferon alfa-2b plus doxorubicin.
Von Hoff DD; Sarosy G; Brown TD; Kuhn JG; Kisner DL
Semin Oncol; 1986 Sep; 13(3 Suppl 2):72-7. PubMed ID: 3764442
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma.
Wadler S; Goldman M; Lyver A; Wiernik PH
Cancer Res; 1990 Apr; 50(7):2056-9. PubMed ID: 2317795
[TBL] [Abstract][Full Text] [Related]
4. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Morton CL; Adkins DA; Rahman A
Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
Bible KC; Kaufmann SH
Cancer Res; 1997 Aug; 57(16):3375-80. PubMed ID: 9269999
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor and chemotherapeutic agents. Potentiation of cytotoxicity with interferon gamma.
Dawson DE; Gapany M; Burgess RC; Boesen PV; Headley DB
Arch Otolaryngol Head Neck Surg; 1992 Nov; 118(11):1168-71. PubMed ID: 1418895
[TBL] [Abstract][Full Text] [Related]
7. Effect of captopril and thiorphan on the proliferation of human neoplastic cell lines and their influence on cytostatic activity of interferon alpha or cytotoxic activity of doxorubicin.
Kowalski J; Belowski D; Wielgus J; Gabryel B; Klin M; Herman ZS
Arch Immunol Ther Exp (Warsz); 1995; 43(1):47-50. PubMed ID: 8744684
[TBL] [Abstract][Full Text] [Related]
8. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
[TBL] [Abstract][Full Text] [Related]
9. Interferon alfa for the treatment of follicular lymphomas.
Hiddemann W; Griesinger F; Unterhalt M
Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S13-8. PubMed ID: 9672770
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV
J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
[TBL] [Abstract][Full Text] [Related]
11. Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay.
Welander CE; Morgan TM; Homesley HD; Trotta PP; Spiegel RJ
Int J Cancer; 1985 Jun; 35(6):721-9. PubMed ID: 4008100
[TBL] [Abstract][Full Text] [Related]
12. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of dimethyl sulfoxide and antineoplastic combinations against human tumors.
Pommier RF; Woltering EA; Milo G; Fletcher WS
Am J Surg; 1988 May; 155(5):672-6. PubMed ID: 3369622
[TBL] [Abstract][Full Text] [Related]
14. [Application of crossed assay design in test of drug sensitivity in vitro in combined chemotherapy of liver cancer].
Wen YJ
Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):378-80. PubMed ID: 8174486
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.
Wadler S; Schwartz EL
Cancer Res; 1990 Jun; 50(12):3473-86. PubMed ID: 1692761
[TBL] [Abstract][Full Text] [Related]
17. Clinical toxicities of the combination of 5-fluorouracil and recombinant interferon alfa-2a: an unusual toxicity profile.
Wadler S; Lyver A; Wiernik PH
Oncol Nurs Forum; 1989; 16(6 Suppl):12-5. PubMed ID: 2594551
[TBL] [Abstract][Full Text] [Related]
18. [Combination effects of etoposide with other antitumor drugs in vitro and in vivo].
Nishikawa K; Kusama K; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3739-45. PubMed ID: 2596858
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K
Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259
[TBL] [Abstract][Full Text] [Related]
20. Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines.
Hahm HA; Dunn VR; Butash KA; Deveraux WL; Woster PM; Casero RA; Davidson NE
Clin Cancer Res; 2001 Feb; 7(2):391-9. PubMed ID: 11234895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
